Mean fecal egg count per individual before and after administration of a single oral dose albendazole. by Martin Walker (170282)

Synaptopathy at IHC-SGN synapses decreases the peak of the CAP significantly, without changes to peak latency and width. by Maral Budak (6680351)

“…<p>(A) Sound-evoked CAPs of SGN fiber populations with different synaptopathy scenarios at 70dB SPL, averaged over 50 simulations. …”

C4BP is necessary and sufficient for serum-mediated decrease in neutrophil internalization of OpaD+ Gc. by Lacie M. Werner (14710419)

Recovery coefficient. by Masakazu Tsujimoto (22339504)

Subjects:

Results of dose linearity. by Masakazu Tsujimoto (22339504)

Subjects:

Evaluation index results for the JS-10 phantom. by Masakazu Tsujimoto (22339504)

Subjects:

NEMA IEC body phantom. by Masakazu Tsujimoto (22339504)

Subjects:

Relationship between contrast, noise, and CNR. by Masakazu Tsujimoto (22339504)

Subjects:

JS-10 phantom. by Masakazu Tsujimoto (22339504)

Subjects:

The raw data used for the analyses in this study. by Masakazu Tsujimoto (22339504)

Subjects:

Ppk1 levels are not affected by decreasing dendrite arbor size but are reduced when dendrite length increases. by Josephine W. Mitchell (17364781)

Elevated IDO activity in HD mouse brains is decreased by <i>ex-vivo</i> iron chelation. by David W. Donley (3111198)

“…<p>Mouse pups were supplemented with carbonyl iron from postnatal days 10–17 and then were sacrificed at 14 weeks of age. <b>A.</b> Striatal IDO activity is increased in N171-82Q HD mice and significantly decreased by <i>ex vivo</i> iron (III) chelation (50 μM deferoxamine). …”

Validation accuracy of our custom CNN model with the directional filters over 5 folds. by Salih Furkan Atici (12988243)

Identification of metabolites with cell type-specific-dynamics reveals the amino acid class as highly conserved in hiPSC and hNSC and that most of the cell type-specific amino acid... by João Vasconcelos e Sá (8721594)

Definitions of the features selected [50]. by Yu Zhang (12946)

Discovery of a Colon-Targeted Azo Prodrug of Tofacitinib through the Establishment of Colon-Specific Delivery Systems Constructed by 5‑ASA–PABA–MAC and 5‑ASA–PABA–Diamine for the T... by Jiaxing Zhao (3965057)

“…Specifically, compound <b>20g</b> displayed a 3.67-fold decrease of plasma AUC_{(tofacitinib, 0–∞)} and a 9.61-fold increase of colonic AUC_{(tofacitinib, 0–12h)}, compared with tofacitinib at a molar equivalent oral dose. …”

Viral measurements do not predict off-ART rebound in d4 and d5 ART RMs. by Brandon F. Keele (7450001)

Fig 5 - by Lingru Ruan (18995544)

Relative fold change (relative to untreated control cells) of the <i>HER-2</i> gene among LS174T and IEC-18 cells. by Asadollahi Parisa (8837432)

Subjects:

Relative fold change (relative to untreated control cells) of the <i>PTGS-2</i> gene among LS174T and IEC-18 cells. by Asadollahi Parisa (8837432)

Subjects: